BIAF
Price:
$1.22
Market Cap:
$18.88M
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2022-09-01
Stock Exchange
NASDAQ
Ticker
BIAF
According to bioAffinity Technologies, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.52. This represents a change of -40.90% compared to the average of -2.57 of the last 4 quarters.
The mean historical PE Ratio of bioAffinity Technologies, Inc. over the last ten years is -7.82. The current -1.52 PE Ratio has changed 1.84% with respect to the historical average. Over the past ten years (40 quarters), BIAF's PE Ratio was at its highest in in the June 2021 quarter at 3.82. The PE Ratio was at its lowest in in the June 2022 quarter at -11.47.
Average
-7.82
Median
-8.42
Minimum
-18.51
Maximum
-0.88
Discovering the peaks and valleys of bioAffinity Technologies, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.52%
Maximum Annual PE Ratio = -0.88
Minimum Annual Increase = -90.88%
Minimum Annual PE Ratio = -18.51
Year | PE Ratio | Change |
---|---|---|
2023 | -1.62 | 83.52% |
2022 | -0.88 | -90.88% |
2021 | -9.68 | 14.90% |
2020 | -8.42 | -54.50% |
The current PE Ratio of bioAffinity Technologies, Inc. (BIAF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.06
5-year avg
-7.82
10-year avg
-7.82
bioAffinity Technologies, Inc.’s PE Ratio is less than Interpace Biosciences, Inc. (2.49), less than Intelligent Bio Solutions Inc. (-0.24), greater than SeqLL Inc. (-4.58), less than Biocept, Inc. (-0.01), less than T2 Biosystems, Inc. (0), less than Genetic Technologies Limited (-0.21), greater than HTG Molecular Diagnostics, Inc. (-9.57), less than Genetron Holdings Limited (-0.02), less than Psychemedics Corporation (0), greater than Precipio, Inc. (-4.60), greater than null (-2.92),
Company | PE Ratio | Market cap |
---|---|---|
2.49 | $11.72M | |
-0.24 | $6.80M | |
-4.58 | $0 | |
-0.01 | $0 | |
0 | $10.73M | |
-0.21 | $6.23M | |
-9.57 | $1.06M | |
-0.02 | $127.29M | |
0 | $13.76M | |
-4.60 | $8.76M | |
-2.92 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like bioAffinity Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like bioAffinity Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is bioAffinity Technologies, Inc.'s PE Ratio?
How is the PE Ratio calculated for bioAffinity Technologies, Inc. (BIAF)?
What is the highest PE Ratio for bioAffinity Technologies, Inc. (BIAF)?
What is the 3-year average PE Ratio for bioAffinity Technologies, Inc. (BIAF)?
What is the 5-year average PE Ratio for bioAffinity Technologies, Inc. (BIAF)?
How does the current PE Ratio for bioAffinity Technologies, Inc. (BIAF) compare to its historical average?